New chip-based blood test can diagnose heart attacks in minutes

102

New Delhi, Oct 16 (IANS) Scientists on Wednesday reported a new blood test that can diagnose heart attacks in minutes rather than hours, and could be adapted as a tool for first responders and people at home.

Developed by researchers at Johns Hopkins University in the US, the stand-alone blood test provides results in five to seven minutes. It’s also more accurate and more affordable than current methods.

Peng Zheng and his team created a tiny chip with a groundbreaking nanostructured surface on which blood is tested.

“We were able to invent a new technology that can quickly and accurately establish if someone is having a heart attack,” said Zheng, an assistant research scientist at Johns Hopkins.

The proof-of-concept work, which can be modified to detect infectious diseases and cancer biomarkers, has been published in the journal Advanced Science.

Though created for speedy diagnostic work in a clinical setting, the test could be adapted as a hand-held tool that first responders could use in the field, or that people might even be able to use themselves at home.

The chip’s “metasurface” enhances electric and magnetic signals during Raman spectroscopy analysis, making heart attack biomarkers visible in seconds, even in ultra-low concentrations.

The tool is sensitive enough to flag heart attack biomarkers that might not be detected at all with current tests, or not detected until much later in an attack.

Though designed to diagnose heart attacks, the tool could be adapted to detect cancer and infectious diseases, the researchers said.

“We’re talking about speed, we’re talking about accuracy, and we’re talking of the ability to perform measurements outside of a hospital,” said senior author Ishan Barman, a bioengineer in the Department of Mechanical Engineering.

“There is enormous commercial potential,” Barman said. “There’s nothing that limits this platform technology.” The team now plans to refine the blood test and explore larger clinical trials.

–IANS

na/

Go to Source

Disclaimer

The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.

In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.

For any legal details or query please visit original source link given with news or click on Go to Source.

Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.

If you are not willing to accept this disclaimer then we recommend reading news post in its original language.

Online Cricket Play Online